Adam Lezack

CIK: 0002048466

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (60.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BBNX

Beta Bionics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (10 total)

BBNX
Beta Bionics, Inc.
May 22, 2026
Sale(S)
Direct
998 shares at avg. $11.21$11K
BBNX
Beta Bionics, Inc.
May 21, 2026
Award(A)
Direct
17K shares-
BBNX
Beta Bionics, Inc.
May 21, 2026
Sale(S)
Direct
1K shares at avg. $9.95$10K
BBNX
Beta Bionics, Inc.
Jan 13, 2026
Award(A)
Direct
4K shares-
BBNX
Beta Bionics, Inc.
Dec 1, 2025
Sale(S)
Direct
906 shares at avg. $29.35$27K
BBNX
Beta Bionics, Inc.
Dec 1, 2025
Sale(S)
Direct
500 shares at avg. $29.91$15K
BBNX
Beta Bionics, Inc.
Oct 31, 2025
Sale(S)
Direct
38 shares at avg. $27.70$1K
BBNX
Beta Bionics, Inc.
Oct 31, 2025
Sale(S)
Direct
1.4K shares at avg. $26.85$37K
BBNX
Beta Bionics, Inc.
Mar 15, 2025
Award(A)
Direct
11.2K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Director Stock Option (right to buy)
Direct
9.1K shares-

		Type	Shares	Price		Ownership
May 22, 2026	BBNX Beta Bionics, Inc.	Sale(S)	998	$11.21	$11,188	Direct
May 21, 2026	BBNX Beta Bionics, Inc.	Award(A)	16,965	-	$0	Direct
May 21, 2026	BBNX Beta Bionics, Inc.	Sale(S)	1,000	$9.95	$9,950	Direct
Jan 13, 2026	BBNX Beta Bionics, Inc.	Award(A)	3,997	-	$0	Direct
Dec 1, 2025	BBNX Beta Bionics, Inc.	Sale(S)	906	$29.35	$26,588	Direct
Dec 1, 2025	BBNX Beta Bionics, Inc.	Sale(S)	500	$29.91	$14,955	Direct
Oct 31, 2025	BBNX Beta Bionics, Inc.	Sale(S)	38	$27.70	$1,053	Direct
Oct 31, 2025	BBNX Beta Bionics, Inc.	Sale(S)	1,368	$26.85	$36,727	Direct
Mar 15, 2025	BBNX Beta Bionics, Inc.	Award(A)	11,247	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Director Stock Option (right to buy)	9,137	-	-	Direct

1-10 of 10 transactions

About Lezack Adam

Lezack Adam (SEC CIK 0002048466) files insider reports with the SEC as Director of Beta Bionics, Inc. (BBNX).

Signal8 holds 7 ownership filings by Lezack Adam (1 Form 3, 6 Form 4), filed between Jan 29, 2025 and May 26, 2026. Those filings report 10 transactions, from Jan 31, 2025 to May 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lezack Adam's filings is in IRVINE, CA.

Recent filings by Lezack Adam

May 22, 2026: Open-market sale of BBNX shares (Form 4, code S).
May 21, 2026: Grant or award of BBNX shares (Form 4, code A).
May 21, 2026: Open-market sale of BBNX shares (Form 4, code S).
Jan 13, 2026: Grant or award of BBNX shares (Form 4, code A).
Dec 1, 2025: Open-market sales of BBNX shares (2 lines, Form 4, code S).

Other insiders filing for Beta Bionics, Inc. (BBNX)

Mensinger Mike, Chief Product Officer
Hopman Mark, Chief Commercial Officer
Jones Christy, Director
Saint Sean, President & CEO
Russell Steven Jon, Chief Medical Officer
Feider Stephen, Chief Financial Officer

How to read Form 4 transaction codes